Giant Biogene's (HKG:2367) controlling shareholder, Juzi Holding, is planning to increase its shareholding in the company, a Monday Hong Kong bourse filing said.
Juzi will acquire at least HK$200 million of shares in the biotechnological product maker within the next three to six months.
As of Monday, Juzi holds 581,104,935, or 54.26%, shares in Giant Biogene.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.